TARGETING CD46 FOR BOTH ADENOCARCINOMA AND NEUROENDOCRINE PROSTATE CANCER ArticleSu Y., Liu Y., Behrens C.R., Bidlingmaier S., Lee N.K., Liu B., Aggarwal R., Sherbenou D.W., Shuman M.A., Small E.J., Hann B.C., Simko J.P., Premasekharan G., Paris P.L., Burlingame A.L., Seo Y.JCI Insight. Том 3. 2018.
